Prospective evaluation of 68Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: Preliminary results from a single centre study

European Radiology

Volumn 22, Issue 3, 2012, Pages 710-719

  Naswa, Niraj ^a   Sharma, Punit ^a   Nazar, Aftab Hasan ^a   Agarwal, Krishan Kant ^a   Kumar, Rakesh ^a   Ammini, Ariachery C ^a   Malhotra, Arun ^a   Bal, Chandrasekhar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

68Ga DOTA NOC; MIBG; Paraganglioma; PET CT; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID GALLIUM 68 SODIUM IODIDE 3 OCTREOTIDE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 68GA TETRAAZACYCLODODECANE TETRAACETIC ACID NAL(3) OCTREOTIDE; 68GA-TETRAAZACYCLODODECANE TETRAACETIC ACID-NAL(3)-OCTREOTIDE; DIAGNOSTIC AGENT; ORGANOMETALLIC COMPOUND;

ADOLESCENT; ADULT; AGED; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG TUMOR LEVEL; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; OUTCOME ASSESSMENT; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR SCINTISCANNING; WHOLE BODY PET; ADRENAL TUMOR; ARTICLE; MIDDLE AGED; NONPARAMETRIC TEST; SCINTISCANNING;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 84856624361     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2289-x     Document Type: Review

References (34)

1. RW Gifford Jr WM Manger EL Bravo 1994 Pheochromocytoma Endocrinol Metab Clin North Am 23 387 404 8070429 (Pubitemid 24191812)
2. SS Werbel KP Ober 1995 Pheochromocytoma: update on diagnosis, localization, and management Med Clin North Am 79 131 153 7808088 1:STN:280:DyaK2M7gs12jsg%3D%3D
3. Manger WM, Gifford RW (1995) Pheochromocytoma: a clinical overview. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management. Raven, New York, pp 225-244
4. HPH Neumann DP Berger G Sigmund, et al. 1993 Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel- Lindau disease N Engl J Med 329 1531 1538 8105382 10.1056/NEJM199311183292103 1:STN:280:DyaK2c%2FhvFKnsA%3D%3D (Pubitemid 23332438)
5. SG Moreira Jr JM Pow-Sang 2002 Evaluation and management of adrenal masses Cancer Control 9 326 334 12228758 (Pubitemid 34921038)
6. EL Bravo 1994 Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma Endocr Rev 15 356 368 8076587 1:CAS:528: DyaK2cXlslKhur0%3D (Pubitemid 24180793)
7. RivaC CapellaC M Cornaggia, et al. 1988 Histopathology, cytology and cytochemistry of pheochromocytomas and paragangliomas including chemodectomas Path Res Pract 183 176 187 10.1016/S0344-0338(88)80045-1
8. S Grufferman MW Gillman LR Pasternak, et al. 1980 Familial carotid body tumors: case report and epidemiologic review Cancer 46 2116 2122 7000334 10.1002/1097-0142(19801101)46:9<2116::AID-CNCR2820460934>3.0.CO;2-S 1:STN:280:DyaL3M%2Fkt1SjsQ%3D%3D (Pubitemid 10025492)
9. KE Kliewer DR Wen PA Cancilla, et al. 1989 Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques Hum Pathol 20 29 39 2912871 10.1016/0046-8177(89)90199-8 1:STN:280: DyaL1M7gvVCisg%3D%3D (Pubitemid 19041992)
10. EE Lack AL Cubilla JM Woodruff 1979 Paragangliomas of the head and neck region. A pathologic study of tumors from 71 patients Hum Pathol 10 191 218 422190 10.1016/S0046-8177(79)80008-8 1:STN:280:DyaE1M7ivFagug%3D%3D (Pubitemid 9170080)
11. YC Kudva AM Sawka WF Young Jr 2003 Clinical review 164: the laboratory diagnosis of adrenal pheochromocytoma-the Mayo Clinic experience J Clin Endocrinol Metab 88 4533 4539 14557417 10.1210/jc.2003-030720 1:CAS:528:DC%2BD3sXoslemsLo%3D (Pubitemid 37357488)
12. HPH Neumann BU Bender M Reincke, et al. 1999 Adrenal sparing surgery for pheochromocytoma Br J Surg 84 94 97 10.1046/j.1365-2168.1999.00974.x (Pubitemid 29051916)
13. 131I MIBG scintigraphy Radiology 165 89 93 3628794 1:STN:280:DyaL2szhvVKgtw%3D%3D (Pubitemid 17146987)
14. CS Connor AS Hermreck JH Thomas 1988 Pitfalls in the diagnosis of pheochromocytoma Am Surg 54 634 636 3178050 1:STN:280:DyaL1M%2FisVaisg%3D%3D
15. 131I MIBG uptake by pheochromocytoma and normal tissues J Nucl Med 30 481 489 2738677 1:STN:280:DyaL1M3ptlaqsQ%3D%3D (Pubitemid 19096593)
16. YC Patel 1999 Somatostatin and its receptor family Front Neuroendocrinol 20 157 198 10433861 10.1006/frne.1999.0183 1:CAS:528:DyaK1MXkvVOrsLc%3D (Pubitemid 29362641)
17. M Jochen U Nicole S Stefan, et al. 2003 Somatostatin Receptor Subtypes in Human Pheochromocytoma: Subcellular Expression Pattern and Functional Relevance for Octreotide Scintigraphy J Clin Endocrinol Metab 88 5150 5157 10.1210/jc.2003-030262 (Pubitemid 37452710)
18. E Van der Harst WW De Herder HA Bruining, et al. 2000 123[I] Metaiodobenzylguanidine and 111[In] octreotide uptake in benign and malignant pheochromocytomas J Clin Endocrinol Metab 86 685 693 10.1210/jc.86.2.685 (Pubitemid 32207482)
19. 68Ga for Medical Application J Nucl Med 48 1741 1748 17873136 10.2967/jnumed.107.040378 1:CAS:528:DC%2BD2sXht1GlurnE (Pubitemid 47572722)
20. B Eriksson H Orlefors K Oberg, et al. 2005 Developments in PET for the detection of endocrine tumours Best Pract Res Clin Endocrinol Metab 19 311 324 15763703 10.1016/j.beem.2004.11.001 1:STN:280:DC%2BD2M7jtFygug%3D%3D (Pubitemid 40347819)
21. 18F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature? J Nucl Med 50 711 717 19372492 10.2967/jnumed.108.060731 1:CAS:528:DC%2BD1MXmtV2iu7g%3D
22. BL Shuklin NW Thompson B Shapiro, et al. 1999 Pheochromocytomas: Imaging with 2-[Fluorine-18] fluoro-2-deoxy-D-glucose PET Radiology 212 35 41 (Pubitemid 29302508)
23. 11C Hydroxyephedrine PET Radiology 230 423 428 14752186 10.1148/radiol.2302021678 (Pubitemid 38133802)
24. 18F DOPA Whole-Body PET-Initial Results Radiology 222 507 512 11818620 10.1148/radiol.2222010622 (Pubitemid 34106126)
25. 68Ga-DOTA-NOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors J Nucl Med 51 669 673 20395323 10.2967/jnumed.109.071712
26. 68Ga-Labeled Peptides in Tumor Imaging J Nucl Med 46 172S 178S 15653666 1:CAS:528:DC%2BD2MXhsVeksb0%3D (Pubitemid 350000989)
27. Z Win A Al-Nahhas D Towey, et al. 2007 68Ga-DOTATATE PET in neuroectodermal tumours: first experience Nucl Med Commun 28 359 363 17414885 10.1097/MNM.0b013e32808ea0b0 (Pubitemid 46569168)
28. F Mantero T Massimo G Arnoldi, et al. 2000 A survey on adrenal incidentaloma in Italy J Clin Endocrinol Metab 85 637 644 10690869 10.1210/jc.85.2.637 1:CAS:528:DC%2BD3cXhtlyhurw%3D (Pubitemid 32273647)
29. B Ueberberg H Tourne A Redman, et al. 2005 Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland Horm Metab Res 37 722 728 16372224 10.1055/s-2005-921092 1:CAS:528:DC%2BD28XisVSjtw%3D%3D (Pubitemid 43028072)
30. HE van der Harst WW de Herder HA Bruining, et al. 2001 (123)I metaiodobenzylguanidine and (111)In octreotide uptake in benign and malignant pheochromocytomas J Clin Endocrinol Metab 86 685 693 11158032 10.1210/jc.86.2.685 (Pubitemid 32207482)
31. G Kaltsas M Korbonits E Heintz, et al. 2001 Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors J Clin Endocrinol Metab 86 895 902 11158063 10.1210/jc.86.2.895 1:CAS:528:DC%2BD3MXht1Knur0%3D (Pubitemid 32207512)
32. L Kölby P Bernhardt V Johanson, et al. 2006 Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas? Ann N Y Acad Sci 1073 491 497 17102116 10.1196/annals.1353.051 (Pubitemid 44912042)
33. H Timmers AP Gimenez-Roqueplo M Mannelli K Pacak 2009 Clinical aspects of SDHx-related pheochromocytoma and paraganglioma Endocr Relat Cancer 16 391 400 19190077 10.1677/ERC-08-0284 1:CAS:528:DC%2BD1MXptlOht70%3D
34. N Burnichon V Rohmer L Amar, et al. 2009 The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas J Clin Endocrinol Metab 94 2817 2827 19454582 10.1210/jc.2008-2504 1:CAS:528:DC%2BD1MXpvFGnt70%3D